
Novartis Pharma (Pak) Ltd
Mosegor Syp 0.25mg/5ml 60ml
Pizotifen 0.25mg/5 mL
Inclusive of all taxes · Pack of 1 Syrup
Pharmacist-picked alternatives
Prescription may be requested
This medicine is marked as relaxed. You can order it now, and our pharmacist may ask for a prescription before dispatch if needed.
Frequently asked
What is Mosegor Syp 0.25mg/5ml 60ml?
Mosegor Syp 0.25mg/5ml 60ml is a syrup containing Pizotifen 0.25mg/5 mL. It is supplied by Novartis Pharma (Pak) Ltd in a 1 pack.How should I take Mosegor Syp 0.25mg/5ml 60ml?
Take Mosegor Syp 0.25mg/5ml 60ml exactly as directed on the pack or by your doctor or pharmacist. Do not exceed the recommended dose.Can I buy Mosegor Syp 0.25mg/5ml 60ml online in Pakistan from Ailaaj?
Yes. Order Mosegor Syp 0.25mg/5ml 60ml on Ailaaj for pharmacist-checked fulfilment and delivery across Pakistan in 1–3 working days when in stock.
Verified by Ailaaj Pharmacist
Licensed · DRAP-compliant
All products are sourced from DRAP-licensed suppliers and verified by our in-house pharmacists before dispatch.
View trust & licensingProduct overview
Mosegor Syp 0.25mg/5ml 60ml is a syrup containing Pizotifen 0.25mg/5 mL. Supplied by Novartis Pharma (Pak) Ltd (1). Available on Ailaaj with pharmacist verification before dispatch.
- Generic name
- Pizotifen 0.25mg/5 mL
- Manufacturer
- Novartis Pharma (Pak) Ltd
- Form
- Syrup
- Pack size
- Pack of 1 Syrup
- Prescription
- Relaxed — may be requested
- MRP
- Rs.179.83
Common side effects
sedation, dry mouth, drowsiness, increased appetite and weight gain
Generic & branded alternatives
Same active ingredients — verified equivalents you can switch to.
Customers also bought

0.45% Nacl (D/S)+5% Dextrose Sol 500ml
Zafa Pharmaceutical Labs (Pvt) Ltd
Rs.120.70

05-141 Dieffenbach Clamps (Slight Cvd), 56mm
Primed Surgical Instruments
Rs.393.25

10% Hypertonic Solution 1000ml
Compounding
Rs.2,500

20% Hypertonic Saline 1000ml
Compounding
Rs.2,258.35

2Blink Eye Drops 15ml
Sante (Pvt) Ltd
Rs.440

2Sum Inj 1g 1Vial
Sami Pharmaceuticals (Pvt) Ltd
Rs.460
